The shifting tides in corporate development, mergers, and acquisitions have given way to an entirely new way of conceptualizing and ...

In recent news, Pfizer Chief Executive Officer Ian Read stated he will step down at the end of 2018 after ...

Pharmaceutical organizations looking to grow into personalized medicine are leveraging high-dollar acquisitions of cell therapy companies to quickly enter the ...

Shareholder activism in the consumer packaged goods industry has been on the rise in the past few years. Shareholder activists ...

As businesses in the consumer products industry continue exploring new avenues and acquisitions for growth, creating value in M&A is ...

2018 marked the 25th anniversary of the Biotechnology International Convention (BIO 2018). The annual convention was fittingly held in Boston, ...

Three Key Takeaways from the Retail Innovation Conference  Last week I had the pleasure of attending the Retail Innovation Conference ...

As global mergers and acquisitions (M&As) are expected to hit a record $3.2 trillion in 2018 after hitting $2.6 trillion ...

For the seventh year in a row, Clarkston Consulting attended the Association for Accessible Medicines (AAM) Annual Meeting.  Many thanks ...

Value-based care models are the future of pharmaceuticals but several obstacles exist slowing the transition from volume selling to value selling. ...

2018 Consumer Products Trends Report In the 2018 Consumer Products Trends Report, Clarkston Consulting evaluates how artificial intelligence, personalization, and ...

According to the Wall Street Journal, US pharmaceutical companies have more than $166 billion in cash overseas. A cash repatriation ...